|
Home : Unsafe Drugs : Avandia : News Articles : Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug | Xconomy Amylin Keeps Its Chin Up After A Rough 2010 With New Diabetes Drug | Xconomy
The agency was burned by past safety controversies with GlaxoSmithKline's rosiglitazone (Avandia) for diabetes and Abbott Laboratories' sibutramine ...
Avandia Case Evaluation Form
This form is secure and encrypted. More information about secure forms and your privacy here.
|




